Nemanja S Damjanov Selected Research

Antirheumatic Agents (DMARD)

1/2020

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nemanja S Damjanov Research Topics

Disease

2	Rheumatoid Arthritis 02/2015 - 01/2012
1	Arthritis (Polyarthritis) 01/2020
1	Necrosis 01/2020
1	Psoriatic Arthritis 01/2020
1	Headache (Headaches) 02/2015
1	Infections 02/2015
1	Hypercholesterolemia 02/2015
1	Nausea 02/2015
1	Systemic Scleroderma (Systemic Sclerosis) 12/2013

Drug/Important Bio-Agent (IBA)

1	Interleukin-12 (IL 12)IBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	InterleukinsIBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Alanine Transaminase (SGPT)IBA 02/2015
1	Transaminases (Aminotransferases)IBA 02/2015
1	2- ((2- (1H- pyrrolo(2,3- b)pyridin- 3- yl)pyrimidin- 4- yl)amino)- 2- methyl- N- (2,2,2- trifluoroethyl)butanamideIBA 02/2015
1	VX (EDIM)IBA 02/2015
1	LipidsIBA 02/2015
1	AntibodiesIBA 12/2013
1	CytokinesIBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012
1	Etanercept (Enbrel)FDA Link 01/2012

Therapy/Procedure

1	Injections 01/2020
1	Therapeutics 01/2020